Description de l'entreprise
BIOTON is an innovative Polish biotechnology company, which provides patients with safe and complete solutions for diabetes care. They are providing day to day support to patients suffering from diabetes all over the world. Their insulins are available in more than 20 countries in Europe, South America, Asia and Africa.
Conseil d'administration & Conseil de surveillance
| PDG |
| Jeremy Launders |
| Conseil d'administration |
| Adam Polonek |
| Conseil de surveillance |
| Jia Li, Dariusz Trzeciak, Ramesh Rajentheran, Nicola Cadei, Jubo Liu, Valery Yeo, Vaidyanathan Viswanath, Tomasz Siembida |
Données de l'entreprise
| Nom: |
BIOTON S.A. |
| Adresse: |
Macierzysz, ul. Poznańska 12,05-850 Ożarów Mazowiecki |
| Téléphone: |
+48 (22) 721 40 00 |
| Fax: |
+48 (22) 721 13 33 |
| Courriel: |
bioinfo@bioton.com
|
| Internet: |
https://bioton.com/en/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
40.20% |
| IPO date: |
31/03/2005 |
Relations avec les investisseurs
| Nom: |
Katarzyna Stalińska |
| Téléphone IR: |
+48 510 018 373 |
| IR-Fax: |
- |
| E-mail IR: |
investor@bioton.com
|
